{"id":"NCT00092534","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)","officialTitle":"A Randomized, Worldwide, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Immunogenicity, and Efficacy on the Incidence of HPV 16/18-Related CIN 2/3 or Worse of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in 16- to 23-Year Old Women - The FUTURE II Study (Females United to Unilaterally Reduce Endo/Ectocervical Disease)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-06-14","primaryCompletion":"2007-07-31","completion":"2025-06-13","firstPosted":"2004-09-28","resultsPosted":"2009-11-26","lastUpdate":"2025-08-01"},"enrollment":12167,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Cervical Cancer","Genital Warts"],"interventions":[{"type":"BIOLOGICAL","name":"Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine","otherNames":["V501, qHPV vaccine"]},{"type":"BIOLOGICAL","name":"Matching Placebo","otherNames":[]}],"arms":[{"label":"Quadrivalent Human Papillomavirus (HPV) Vaccine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary purpose of the study is to determine if GARDASILâ„¢ (V501) is able to prevent cervical cancer.","primaryOutcome":{"measure":"Incidence of the Composite Endpoint of Human Papillomavirus (HPV) 16/18-related Cervical Intraepithelial Neoplasia (CIN) 2 or Worse in the Base Study","timeFrame":"Up to 4 years","effectByArm":[{"arm":"Base Study Group 1: qHPV Vaccine","deltaMin":0,"sd":null},{"arm":"Base Study Group 2: Placebo","deltaMin":0.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"16 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["17494925","19199546","18313445","17512854","18000825","18008221","17544766","17955433","19505910","17943470","26084514","18555997","19453788","19789295","20647284","19855170","21491420","29029053","35149535","32247041","32184277","30982556","29995724","29074187","23299013","23066159","22454089","21471141","20949623","19935017","19236279","19236277"],"seeAlso":["https://www.merckclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":6082},"commonTop":["Injection site pain","Headache","Injection site erythema","Injection site swelling"]}}